Truist Financial’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-19,445
Closed -$277K – 2715
2020
Q4
$277K Sell
19,445
-235
-1% -$3.16K ﹤0.01% 2209
2020
Q3
$275K Buy
19,680
+565
+3% +$6.73K ﹤0.01% 2075
2020
Q2
$203K Buy
+19,115
New +$194K ﹤0.01% 2182

Other funds holding RDY

Truist Financial's RDY Position: Q1 2021 in Review

Truist Financial sold out of Dr. Reddy's Laboratories (RDY) in Q1 2021, closing a stake of 19,445 shares — an estimated $277K sold.

Truist Financial first reported a position in RDY in Q2 2020 and held it in 3 quarters. The position peaked at $277K in Q4 2020. 160 funds tracked by Wall St. Rank hold RDY as of Q1 2021.

  • Truist Financial reported no remaining Dr. Reddy's Laboratories position as of Q1 2021 after selling out during the quarter.
  • Truist Financial sold 19,445 Dr. Reddy's Laboratories shares in Q1 2021, an estimated $277K.
  • Truist Financial first reported a position in Dr. Reddy's Laboratories in Q2 2020 and held it in 3 quarters.
  • Truist Financial's Dr. Reddy's Laboratories position peaked at $277K in Q4 2020.
  • 160 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2021.

Based on Truist Financial's 13F filing for Q1 2021, filed 17 May 2021.